Navigation Links
Flu Vaccine Can Be Used To Treat Lung Cancer

A group of researchers at Vienna University have said they are trying to develop an existing influenza vaccine so that it will be effective against lung cancer//.

Experiments with mice have already yielded first successes, but much more research was still needed before the new therapy could be used on humans, said a university statement Tuesday.

"In fact it's a paradox," said research scientist Christian Kittel at the Institute of Applied Microbiology.

"Influenza viruses normally cause flu in human beings, and thereby an extremely dangerous illness, which for some patients even ends fatally."

"But now we want to treat an even more dangerous illness, lung cancer, with them," he said.

The researchers explained that the human immune system usually stands no chance against cancer, as it cannot distinguish between healthy and cancerous cells.

But now they had succeeded in altering an existing influenza vaccine so that it acted on the immune system like a sparkplug, giving it a kick-start. Then the system becomes so highly sensitised that it could recognise cancer cells and destroy them, scientists explained.

The existing vaccine was attenuated - a toned-down influenza virus, which could not cause the disease itself but still infected the lungs.

The researchers had developed the virus further so that it now also contained the building plan for production of the immune "messenger" Interleukin-2. This material had already previously been gene-technically manufactured and tested.

"But it was administered to the patients systematically (by infection) and in high dosages. That did in fact have an effect, but also strong side-effects."

This problem would be avoided by using the influenza viruses as conveyances. The virus-infected cells of the lungs would then produce and release the Interleukin-2 just where it was needed.

The substance would activa te the pulmonary immune system to such an extent that it could recognise and fight the cancer.

--DPA
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Injectables Market and Increasing Usage of Complex Biologics during the Forecast ... ... USD 20 Billion in 2015 to around USD 26 Billion by ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: